MedPath

VisiOn Restoration With FluidVisION Accommodating Intraocular Lens (AIOL)

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: FluidVision AIOL
Procedure: Cataract surgery
Device: AcrySof IQ monofocal IOL
Registration Number
NCT03925545
Lead Sponsor
PowerVision
Brief Summary

The objective of this study is to obtain an initial assessment of the safety and performance of an investigational AIOL in patients undergoing cataract extraction and IOL implantation.

Detailed Description

This study was originally designed as a single arm, unilateral study (one eye, one product only) to obtain an initial assessment of the safety and performance of an investigational IOL in subjects undergoing cataract extraction and IOL implantation. The study design was later modified to a contralateral study (both eyes, different product in each eye) to compare the safety and performance of the investigational IOL to a commercially available monofocal IOL.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • Corrected distance visual acuity (CDVA) worse than 20/40, or presence of visually significant lens opacity;
  • Preoperative or predicted postoperative astigmatism of ≤ 1.0 diopter (D);
  • Calculated IOL power within range.

Key

Exclusion Criteria
  • Current medication that may affect accommodation;
  • Systemic disease or concomitant medication that may increase operative risk or confound results;
  • Ocular conditions that may predispose the subject for future complications;
  • Monocular subjects or subjects with significant permanent visual function loss in fellow eye;
  • Previous intraocular or corneal surgery in either eye that may confound the results or increase the risk to the subject, including implantation of a multifocal IOL or other presbyopic corrective surgery in the fellow eye;
  • Grade 4 cataract of any type.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
UnilateralFluidVision AIOLImplantation with the FluidVision AIOL in one eye during cataract surgery. Only one eye was treated.
UnilateralCataract surgeryImplantation with the FluidVision AIOL in one eye during cataract surgery. Only one eye was treated.
ContralateralAcrySof IQ monofocal IOLImplantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery
ContralateralCataract surgeryImplantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery
ContralateralFluidVision AIOLImplantation with the FluidVision AIOL in the first eye during cataract surgery, followed by implantation with the AcrySof IQ monofocal IOL in the fellow eye during a subsequent cataract surgery
Primary Outcome Measures
NameTimeMethod
Distance Corrected Visual AcuityMonth 6 postoperative

Visual acuity was measured with distance correction (plus or minus power) in place.

International Organization for Standardization (ISO)-defined Cumulative and Persistent Adverse Events for Posterior Chamber IOLUp to Month 6 postoperative

Adverse events were categorized per ISO 11979-7: Ophthalmic Implants - Intraocular Lenses - Part 7: Clinical Investigations.

Accommodative Amplitude (AA)Month 6 postoperative

Accommodative amplitude is the ability of the eye to change its focus from distant to near objects.

Secondary Outcome Measures
NameTimeMethod
Uncorrected Visual AcuityUp to Month 6 postoperative

Visual acuity was measured without correction in place.

Minimum Add Power Required to Achieve Best Corrected Near Visual AcuityUp to Month 6 postoperative

Plus lenses were placed over the subject's best distance manifest correction.

Accommodative AmplitudeMonth 3 postoperative

Accommodative amplitude is a measure of the range of vision with good acuity.

© Copyright 2025. All Rights Reserved by MedPath